Prestige closes Breathe Right acquisition for $1B
Share
- Prestige Consumer Healthcare closed its acquisition of the Breathe Right brand.
- The company completed the $1.045 billion transaction using cash and debt.
- The acquisition expands the company's product portfolio into a new category.
Prestige Consumer Healthcare (NYSE:PBH) closed its acquisition of the Breathe Right brand for $1.045 billion.
This closing completes an asset purchase agreement originally announced on March 20, 2026.
The net cost is approximately $900 million after deducting $150 million in anticipated tax benefits.
Prestige financed the brand transaction through available cash and a new Term Loan B.
Following the announcement, Prestige Consumer Healthcare's share price was down at $46.67.
Breathe Right was created in the 1990s within the nasal strip category.
The company stated that the brand will become its largest product line.
More from United States
Arm Q2 revenue hits $1.44B as AI chip demand surges
Qualcomm Q4 earnings beat estimates as auto sales jump 89%
Melco Resorts Q3 revenue falls 10% to $1.17 billion
Emerson Q4 revenue accelerates 7% to $5.2 billion
Flowco Q3 revenue revs up 46% to $258.6 million
Clear secure Q3 revenue hits $292.9M as top line expands 27.8%
